NCT02834975 2023-11-07Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).University of MiamiPhase 2 Terminated26 enrolled 11 charts
NCT02900560 2022-06-10Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian CancerTranslational Research in OncologyPhase 2 Terminated34 enrolled 15 charts